{"id":"https://openalex.org/W2394823257","doi":null,"title":"Cytokine therapy for hematological malignancies.","display_name":"Cytokine therapy for hematological malignancies.","publication_year":1997,"publication_date":"1997-05-01","ids":{"openalex":"https://openalex.org/W2394823257","mag":"2394823257","pmid":"https://pubmed.ncbi.nlm.nih.gov/9210900"},"language":"en","primary_location":{"id":"pmid:9210900","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9210900","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2394823257"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112955720","display_name":"K Ezaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145673806","display_name":"Fujita Health University","ror":"https://ror.org/046f6cx68","country_code":"JP","type":"education","lineage":["https://openalex.org/I145673806"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K Ezaki","raw_affiliation_strings":["Department of Internal Medicine, Fujita Health University, School of Medicine, Aichi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Fujita Health University, School of Medicine, Aichi, Japan","institution_ids":["https://openalex.org/I145673806"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078192175","display_name":"Masayuki Tsuzuki","orcid":"https://orcid.org/0000-0002-0642-1143","observed_orcids":["https://orcid.org/0000-0002-0642-1143"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Tsuzuki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"24 Suppl 1","issue":null,"first_page":"182","last_page":"94"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.7616999745368958,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.7616999745368958,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.11309999972581863,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.05400000140070915,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytokine-therapy","display_name":"cytokine therapy","score":0.9940000176429749},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.9900000095367432},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8159999847412109},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9259999990463257},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.8659999966621399},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.9739999771118164},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7369999885559082},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8180000185966492},{"id":"https://openalex.org/keywords/allogeneic-bone-marrow-transplantation","display_name":"allogeneic bone marrow transplantation","score":0.8379999995231628},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.9580000042915344},{"id":"https://openalex.org/keywords/stem-cell-mobilization","display_name":"stem cell mobilization","score":0.8330000042915344},{"id":"https://openalex.org/keywords/chemotherapy-induced-neutropenia","display_name":"chemotherapy-induced neutropenia","score":0.5149999856948853},{"id":"https://openalex.org/keywords/anticancer-mechanism","display_name":"anticancer mechanism","score":0.6669999957084656},{"id":"https://openalex.org/keywords/biological-response-modifiers","display_name":"biological response modifiers","score":0.7649999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.80399489402771},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6330441236495972},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5812645554542542},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5207455158233643},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.49113866686820984},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.48540863394737244},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.47440218925476074},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.469608873128891},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4601507782936096},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.45118504762649536},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.43539106845855713},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39994460344314575},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.390497624874115},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09360957145690918},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002066","descriptor_name":"Busulfan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006918","descriptor_name":"Hydroxyurea","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015466","descriptor_name":"Leukemia, Myeloid, Chronic-Phase","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016178","descriptor_name":"Granulocyte-Macrophage Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9210900","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9210900","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Journal Article"},{"id":"mag:2394823257","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9210900","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W796533230","https://openalex.org/W2072494396","https://openalex.org/W2049098874","https://openalex.org/W111362309","https://openalex.org/W1901905837","https://openalex.org/W1964987530","https://openalex.org/W2048266944","https://openalex.org/W2079691983","https://openalex.org/W2021696637","https://openalex.org/W2024706907"],"abstract_inverted_index":{"Recently":[0],"various":[1],"cytokines":[2,46],"have":[3,10,25,67,151,173,202,242],"been":[4,68,175,243,262],"introduced":[5],"into":[6],"the":[7,16,43,81,104,115,130,153,186],"clinic":[8],"and":[9,30,56,84,148,161,183,207,225],"played":[11],"important":[12],"therapeutic":[13],"roles":[14],"in":[15,47,60,70,78,92,100,110,125,210,227,231],"treatment":[17,120],"of":[18,53,80,106,119,129,133,155,158,163,189],"hematological":[19,61],"malignancies.":[20,62],"Among":[21],"these":[22,101],"cytokines,":[23],"we":[24],"focused":[26],"on":[27],"interferon":[28],"(IFN)":[29],"granulocyte":[31],"(G)":[32],"or":[33,168],"granulocyte-macrophage":[34],"(GM)":[35],"colony":[36],"stimulating":[37],"factor":[38],"(CSF),":[39],"which":[40],"are":[41,76],"currently":[42],"most":[44,54,64,116],"useful":[45,55],"this":[48],"review.":[49],"IFN-a":[50],"is":[51,121],"one":[52],"wide-ranging":[57],"antitumor":[58,131],"agents":[59],"The":[63],"striking":[65],"effects":[66],"studies":[69,217],"chronic":[71],"phase":[72],"CML.":[73],"Cytogenetic":[74],"responses":[75],"seen":[77,91],"30-40%":[79],"treated":[82],"patients,":[83],"a":[85,136],"complete":[86],"cytogenetic":[87],"response":[88,141,211],"can":[89,97,221],"be":[90,98,222],"about":[93],"10%.":[94],"Long-term":[95],"survival":[96],"expected":[99],"patients.":[102,127],"Considering":[103],"risk":[105],"graft-versus-host":[107],"disease-associated":[108],"mortality":[109],"allogeneic":[111],"bone":[112],"marrow":[113],"transplantation,":[114],"appropriate":[117],"category":[118],"difficult":[122],"to":[123,177,184,212,245,255],"determine":[124],"IFN-responsive":[126],"Elucidation":[128],"mechanism":[132],"IFN,":[134],"as":[135],"prototype":[137],"for":[138,205],"other":[139],"biological":[140],"modifiers,":[142],"may":[143,208],"revolutionize":[144],"cancer":[145,166],"treatment.":[146],"G-":[147],"GM-CSF":[149],"(CSFs)":[150],"reduced":[152],"duration":[154],"neutropenia,":[156],"incidence":[157],"infectious":[159],"episodes":[160],"days":[162],"hospitalization":[164],"following":[165],"chemotherapy":[167],"stem":[169,181],"cell":[170],"transplantation.":[171],"CSFs":[172,206,220],"also":[174],"used":[176,223],"mobilize":[178],"peripheral":[179],"blood":[180],"cells":[182,193,248],"increase":[185],"dose":[187],"intensity":[188],"chemotherapeutic":[190],"agents.":[191],"Leukemic":[192],"from":[194],"many":[195],"patients":[196,232],"with":[197,233],"acute":[198],"myelogenous":[199],"leukemia":[200],"(AML)":[201],"surface":[203],"receptors":[204],"proliferate":[209],"CSFs.":[213],"However,":[214],"several":[215],"randomized":[216],"showed":[218],"that":[219],"safely":[224],"effectively":[226],"augmenting":[228],"neutrophil":[229],"recovery":[230],"AML":[234],"when":[235],"given":[236],"after":[237],"induction":[238],"chemotherapy.":[239],"Various":[240],"trials":[241],"conducted":[244],"sensitize":[246],"leukemic":[247],"by":[249],"CSFs,":[250],"making":[251],"them":[252],"more":[253],"susceptible":[254],"chemotherapy;":[256],"but":[257],"no":[258],"convincing":[259],"evidence":[260],"has":[261],"obtained.":[263]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}